Immunoprecise Antibodies Ltd (IPA) — Free Cash Flow Generation Index
Immunoprecise Antibodies Ltd (IPA) has a Free Cash Flow Generation Index of -0.62x as of October 2020. Free cash flow of $-274.98K represents -1% of operating cash flow ($440.23K). Read IPA total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Immunoprecise Antibodies Ltd Free Cash Flow Generation Index (2016–2016)
Historical FCF Generation Index trend for Immunoprecise Antibodies Ltd across 1 annual periods. Explore how much does Immunoprecise Antibodies Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Immunoprecise Antibodies Ltd (2016–2016)
Year-by-year Free Cash Flow Generation Index for Immunoprecise Antibodies Ltd. For the full company profile including market capitalisation, see Immunoprecise Antibodies Ltd market capitalisation.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2016 | 0.94x | $266.61K | $284.09K | $17.48K | — |